Phase 1/2 study of lumasiran for treatment of primary hyperoxaluria type 1 a placebo-controlled randomized clinical trial

Study collaborators

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase 1/2 study of lumasiran for treatment of primary hyperoxaluria type 1 a placebo-controlled randomized clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences